U72-23267-42322
3 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 145 / NY
- Registered
- 2022-07-30
- Relationship
- Child or adolescent in my care
- Guardian
- 577-11818-92124
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-28
Dose 1 — Pfizer-BioNTechCo-administered: Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus
-
2022-07-30
Registered in v-safe
- 2022-07-30
- 2022-07-31
-
2022-08-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-08-03
- 2022-08-11
-
2022-08-18
Dose 2 — Pfizer-BioNTech
- 2022-08-18
- 2022-08-19
- 2022-08-20
- 2022-08-22
- 2022-08-23
- 2022-08-25
- 2022-09-04
- 2022-09-08
- 2022-09-22
- 2022-09-29
-
2022-11-10
Dose 3 — Pfizer-BioNTechCo-administered: Flu:Hepatitis B
-
2022-11-17
Survey response — day 7, dose 3, under 3MedDRA: Respiratory tract congestion — Feeling: FairFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Survey response — 3 months, dose 2, under 3MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to do your normal daily activitiesFree text: Rsv infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-26
Survey response — day 14, dose 3, under 3MedDRA: Conjunctivitis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion and bilateral watery conjunctivitisMedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
-
2022-12-10
Survey response — day 28, dose 3, under 3MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-15
- 2023-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-28 | Pfizer-BioNTech | Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus |
| 2 | 2022-08-18 | Pfizer-BioNTech | No |
| 3 | 2022-11-10 | Pfizer-BioNTech | Flu:Hepatitis B |
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Rsv infection
Release 12 (Under 3) — day 7, dose 3, under 3
Systemic reaction (other): Congestion
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Congestion and bilateral watery conjunctivitis
Release 12 (Under 3) — day 28, dose 3, under 3
Symptoms: Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release